Voythos

About Voythos

Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. This technology aims to reduce mortality and limb loss associated with acute cardiovascular events.

```xml <problem> Type B aortic dissections are complex cardiovascular conditions that can lead to life-threatening complications, including mortality and limb loss. Early detection and intervention are critical, but predicting which patients are most at risk remains a challenge. </problem> <solution> Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. The technology analyzes diverse data inputs to identify patients at high risk of acute cardiovascular events. By providing clinicians with predictive insights, Voythos aims to reduce mortality and limb loss associated with these dissections. The company is currently in the development phase and not yet selling its services. </solution> <features> - Multimodal machine learning models for risk prediction - Analysis of diverse data inputs to identify high-risk patients - Predictive insights to enable earlier intervention </features> <target_audience> The primary target audience is cardiovascular surgeons and medical professionals involved in the treatment of Type B aortic dissections. </target_audience> ```

What does Voythos do?

Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. This technology aims to reduce mortality and limb loss associated with acute cardiovascular events.

Where is Voythos located?

Voythos is based in Houston, United States.

When was Voythos founded?

Voythos was founded in 2023.

How much funding has Voythos raised?

Voythos has raised 180000.

Location
Houston, United States
Founded
2023
Funding
180000
Employees
2 employees
Major Investors
Forum Ventures
Looking for specific startups?
Try our free semantic startup search

Voythos

Score: 66/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. This technology aims to reduce mortality and limb loss associated with acute cardiovascular events.

voythos.io200+
cb
Crunchbase
Founded 2023 – Houston, United States

Funding

$

Estimated Funding

$180K+

Major Investors

Forum Ventures

Team (<5)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

Type B aortic dissections are complex cardiovascular conditions that can lead to life-threatening complications, including mortality and limb loss. Early detection and intervention are critical, but predicting which patients are most at risk remains a challenge.

Solution

Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. The technology analyzes diverse data inputs to identify patients at high risk of acute cardiovascular events. By providing clinicians with predictive insights, Voythos aims to reduce mortality and limb loss associated with these dissections. The company is currently in the development phase and not yet selling its services.

Features

Multimodal machine learning models for risk prediction

Analysis of diverse data inputs to identify high-risk patients

Predictive insights to enable earlier intervention

Target Audience

The primary target audience is cardiovascular surgeons and medical professionals involved in the treatment of Type B aortic dissections.